Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan.

Vennin C, Mélénec P, Rouet R, Nobis M, Cazet AS, Murphy KJ, Herrmann D, Reed DA, Lucas MC, Warren SC, Elgundi Z, Pinese M, Kalna G, Roden D, Samuel M, Zaratzian A, Grey ST, Da Silva A, Leung W; Australian Pancreatic Genome Initiative (APGI), Mathivanan S, Wang Y, Braithwaite AW, Christ D, Benda A, Parkin A, Phillips PA, Whitelock JM, Gill AJ, Sansom OJ, Croucher DR, Parker BL, Pajic M, Morton JP, Cox TR, Timpson P.

Nat Commun. 2019 Aug 12;10(1):3637. doi: 10.1038/s41467-019-10968-6.

2.

Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.

Balachandran VP, Łuksza M, Zhao JN, Makarov V, Moral JA, Remark R, Herbst B, Askan G, Bhanot U, Senbabaoglu Y, Wells DK, Cary CIO, Grbovic-Huezo O, Attiyeh M, Medina B, Zhang J, Loo J, Saglimbeni J, Abu-Akeel M, Zappasodi R, Riaz N, Smoragiewicz M, Kelley ZL, Basturk O; Australian Pancreatic Cancer Genome Initiative; Garvan Institute of Medical Research; Prince of Wales Hospital; Royal North Shore Hospital; University of Glasgow; St Vincent’s Hospital; QIMR Berghofer Medical Research Institute; University of Melbourne, Centre for Cancer Research; University of Queensland, Institute for Molecular Bioscience; Bankstown Hospital; Liverpool Hospital; Royal Prince Alfred Hospital, Chris O’Brien Lifehouse; Westmead Hospital; Fremantle Hospital; St John of God Healthcare; Royal Adelaide Hospital; Flinders Medical Centre; Envoi Pathology; Princess Alexandria Hospital; Austin Hospital; Johns Hopkins Medical Institutes; ARC-Net Centre for Applied Research on Cancer, Gönen M, Levine AJ, Allen PJ, Fearon DT, Merad M, Gnjatic S, Iacobuzio-Donahue CA, Wolchok JD, DeMatteo RP, Chan TA, Greenbaum BD, Merghoub T, Leach SD.

Nature. 2017 Nov 23;551(7681):512-516. doi: 10.1038/nature24462. Epub 2017 Nov 8.

3.

Updated Recommendations for Cost-effectiveness Studies.

Maw AM, Shen NT, Fletcher DR.

JAMA. 2017 Jan 3;317(1):89. doi: 10.1001/jama.2016.17833. No abstract available.

PMID:
28030694
4.

IGF-1 and Chondroitinase ABC Augment Nerve Regeneration after Vascularized Composite Limb Allotransplantation.

Kostereva NV, Wang Y, Fletcher DR, Unadkat JV, Schnider JT, Komatsu C, Yang Y, Stolz DB, Davis MR, Plock JA, Gorantla VS.

PLoS One. 2016 Jun 7;11(6):e0156149. doi: 10.1371/journal.pone.0156149. eCollection 2016.

5.

Genomic analyses identify molecular subtypes of pancreatic cancer.

Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, Miller DK, Christ AN, Bruxner TJ, Quinn MC, Nourse C, Murtaugh LC, Harliwong I, Idrisoglu S, Manning S, Nourbakhsh E, Wani S, Fink L, Holmes O, Chin V, Anderson MJ, Kazakoff S, Leonard C, Newell F, Waddell N, Wood S, Xu Q, Wilson PJ, Cloonan N, Kassahn KS, Taylor D, Quek K, Robertson A, Pantano L, Mincarelli L, Sanchez LN, Evers L, Wu J, Pinese M, Cowley MJ, Jones MD, Colvin EK, Nagrial AM, Humphrey ES, Chantrill LA, Mawson A, Humphris J, Chou A, Pajic M, Scarlett CJ, Pinho AV, Giry-Laterriere M, Rooman I, Samra JS, Kench JG, Lovell JA, Merrett ND, Toon CW, Epari K, Nguyen NQ, Barbour A, Zeps N, Moran-Jones K, Jamieson NB, Graham JS, Duthie F, Oien K, Hair J, Grützmann R, Maitra A, Iacobuzio-Donahue CA, Wolfgang CL, Morgan RA, Lawlor RT, Corbo V, Bassi C, Rusev B, Capelli P, Salvia R, Tortora G, Mukhopadhyay D, Petersen GM; Australian Pancreatic Cancer Genome Initiative, Munzy DM, Fisher WE, Karim SA, Eshleman JR, Hruban RH, Pilarsky C, Morton JP, Sansom OJ, Scarpa A, Musgrove EA, Bailey UM, Hofmann O, Sutherland RL, Wheeler DA, Gill AJ, Gibbs RA, Pearson JV, Waddell N, Biankin AV, Grimmond SM.

Nature. 2016 Mar 3;531(7592):47-52. doi: 10.1038/nature16965. Epub 2016 Feb 24.

PMID:
26909576
6.

Single-Stage Flexor Tendon Grafting: Refining the Steps.

Fletcher DR, McClinton MA.

J Hand Surg Am. 2015 Jul;40(7):1452-60. doi: 10.1016/j.jhsa.2015.04.016. Epub 2015 May 27. Review.

PMID:
26026357
7.

Whole genomes redefine the mutational landscape of pancreatic cancer.

Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, Quinn MC, Robertson AJ, Fadlullah MZ, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Wani S, Wilson PJ, Markham E, Cloonan N, Anderson MJ, Fink JL, Holmes O, Kazakoff SH, Leonard C, Newell F, Poudel B, Song S, Taylor D, Waddell N, Wood S, Xu Q, Wu J, Pinese M, Cowley MJ, Lee HC, Jones MD, Nagrial AM, Humphris J, Chantrill LA, Chin V, Steinmann AM, Mawson A, Humphrey ES, Colvin EK, Chou A, Scarlett CJ, Pinho AV, Giry-Laterriere M, Rooman I, Samra JS, Kench JG, Pettitt JA, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N, Jamieson NB, Graham JS, Niclou SP, Bjerkvig R, Grützmann R, Aust D, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Wolfgang CL, Morgan RA, Lawlor RT, Corbo V, Bassi C, Falconi M, Zamboni G, Tortora G, Tempero MA; Australian Pancreatic Cancer Genome Initiative, Gill AJ, Eshleman JR, Pilarsky C, Scarpa A, Musgrove EA, Pearson JV, Biankin AV, Grimmond SM.

Nature. 2015 Feb 26;518(7540):495-501. doi: 10.1038/nature14169.

8.
9.

Development of a reliable model of total abdominal wall transplantation.

Quigley MA, Fletcher DR, Zhang W, Nguyen VT.

Plast Reconstr Surg. 2013 Oct;132(4):988-94. doi: 10.1097/PRS.0b013e31829f4bd3.

PMID:
24076687
10.

Successful replantation of an amputated midfacial segment: technical details and lessons learned.

Cooney DS, Fletcher DR, Bonawitz SC.

Ann Plast Surg. 2013 Jun;70(6):663-5. doi: 10.1097/SAP.0b013e3182468216.

PMID:
23241762
11.

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.

Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, Patch AM, Wu J, Chang DK, Cowley MJ, Gardiner BB, Song S, Harliwong I, Idrisoglu S, Nourse C, Nourbakhsh E, Manning S, Wani S, Gongora M, Pajic M, Scarlett CJ, Gill AJ, Pinho AV, Rooman I, Anderson M, Holmes O, Leonard C, Taylor D, Wood S, Xu Q, Nones K, Fink JL, Christ A, Bruxner T, Cloonan N, Kolle G, Newell F, Pinese M, Mead RS, Humphris JL, Kaplan W, Jones MD, Colvin EK, Nagrial AM, Humphrey ES, Chou A, Chin VT, Chantrill LA, Mawson A, Samra JS, Kench JG, Lovell JA, Daly RJ, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N; Australian Pancreatic Cancer Genome Initiative, Kakkar N, Zhao F, Wu YQ, Wang M, Muzny DM, Fisher WE, Brunicardi FC, Hodges SE, Reid JG, Drummond J, Chang K, Han Y, Lewis LR, Dinh H, Buhay CJ, Beck T, Timms L, Sam M, Begley K, Brown A, Pai D, Panchal A, Buchner N, De Borja R, Denroche RE, Yung CK, Serra S, Onetto N, Mukhopadhyay D, Tsao MS, Shaw PA, Petersen GM, Gallinger S, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL, Morgan RA, Lawlor RT, Capelli P, Corbo V, Scardoni M, Tortora G, Tempero MA, Mann KM, Jenkins NA, Perez-Mancera PA, Adams DJ, Largaespada DA, Wessels LF, Rust AG, Stein LD, Tuveson DA, Copeland NG, Musgrove EA, Scarpa A, Eshleman JR, Hudson TJ, Sutherland RL, Wheeler DA, Pearson JV, McPherson JD, Gibbs RA, Grimmond SM.

Nature. 2012 Nov 15;491(7424):399-405. doi: 10.1038/nature11547. Epub 2012 Oct 24.

12.

Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression.

Schneeberger S, Gorantla VS, Brandacher G, Zeevi A, Demetris AJ, Lunz JG, Metes DM, Donnenberg AD, Shores JT, Dimartini AF, Kiss JE, Imbriglia JE, Azari K, Goitz RJ, Manders EK, Nguyen VT, Cooney DS, Wachtman GS, Keith JD, Fletcher DR, Macedo C, Planinsic R, Losee JE, Shapiro R, Starzl TE, Lee WP.

Ann Surg. 2013 Feb;257(2):345-51. doi: 10.1097/SLA.0b013e31826d90bb.

13.

RON is not a prognostic marker for resectable pancreatic cancer.

Tactacan CM, Chang DK, Cowley MJ, Humphrey ES, Wu J, Gill AJ, Chou A, Nones K, Grimmond SM, Sutherland RL, Biankin AV, Daly RJ; Australian Pancreratic Genome Initiative.

BMC Cancer. 2012 Sep 7;12:395. doi: 10.1186/1471-2407-12-395.

14.

The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.

Pérez-Mancera PA, Rust AG, van der Weyden L, Kristiansen G, Li A, Sarver AL, Silverstein KA, Grützmann R, Aust D, Rümmele P, Knösel T, Herd C, Stemple DL, Kettleborough R, Brosnan JA, Li A, Morgan R, Knight S, Yu J, Stegeman S, Collier LS, ten Hoeve JJ, de Ridder J, Klein AP, Goggins M, Hruban RH, Chang DK, Biankin AV, Grimmond SM; Australian Pancreatic Cancer Genome Initiative, Wessels LF, Wood SA, Iacobuzio-Donahue CA, Pilarsky C, Largaespada DA, Adams DJ, Tuveson DA.

Nature. 2012 Apr 29;486(7402):266-70. doi: 10.1038/nature11114. Erratum in: Nature. 2013 Feb 21;494(7437):390. Scarlett, Christopher J [added]; Kaplan, Warren [added]; Scarpa, Aldo [added], Das, Amithabad [corrected to Das, Amitabha].

15.

Human facial allotransplantation: patient selection and pertinent considerations.

Losee JE, Fletcher DR, Gorantla VS.

J Craniofac Surg. 2012 Jan;23(1):260-4. doi: 10.1097/SCS.0b013e318241b958.

PMID:
22337421
16.

The outcome of patients on the cholecystectomy waiting list in Western Australia 1999-2005.

Epari KP, Mukhtar AS, Fletcher DR, Samarasam I, Semmens JB.

ANZ J Surg. 2010 Oct;80(10):703-9. doi: 10.1111/j.1445-2197.2010.05428.x. Epub 2010 Aug 16.

PMID:
21040330
17.

Five-year follow-up of a multicenter, double-blind randomized clinical trial of laparoscopic Nissen vs anterior 90 degrees partial fundoplication.

Nijjar RS, Watson DI, Jamieson GG, Archer S, Bessell JR, Booth M, Cade R, Cullingford GL, Devitt PG, Fletcher DR, Hurley J, Kiroff G, Martin IJ, Nathanson LK, Windsor JA; International Society for the Diseases of the Esophagus-Australasian Section.

Arch Surg. 2010 Jun;145(6):552-7. doi: 10.1001/archsurg.2010.81.

PMID:
20566975
18.

Incidence of bariatric surgery and postoperative outcomes: a population-based analysis in Western Australia.

Smith FJ, Holman CD, Moorin RE, Fletcher DR.

Med J Aust. 2008 Aug 18;189(4):198-202.

PMID:
18707562
19.

True incidence of all complications following immediate and delayed breast reconstruction.

Sullivan SR, Fletcher DR, Isom CD, Isik FF.

Plast Reconstr Surg. 2008 Jul;122(1):19-28. doi: 10.1097/PRS.0b013e3181774267.

PMID:
18594356
20.

The safety and efficacy of the StarClose Vascular Closure System: the ultrasound substudy of the CLIP study.

Jaff MR, Hadley G, Hermiller JB, Simonton C, Hinohara T, Cannon L, Reisman M, Braden G, Fletcher DR, Zapien M, Chou TM, DiDonato K.

Catheter Cardiovasc Interv. 2006 Nov;68(5):684-9.

PMID:
17039509
21.

The StarClose Vascular Closure System: interventional results from the CLIP study.

Hermiller JB, Simonton C, Hinohara T, Lee D, Cannon L, Mooney M, O'Shaughnessy C, Carlson H, Fortuna R, Zapien M, Fletcher DR, DiDonato K, Chou TM.

Catheter Cardiovasc Interv. 2006 Nov;68(5):677-83.

PMID:
17039508
22.

Quality of life following laparoscopic anterior 90 degrees versus Nissen fundoplication: results from a multicenter randomized trial.

Woodcock SA, Watson DI, Lally C, Archer S, Bessell JR, Booth M, Cade R, Cullingford GL, Devitt PG, Fletcher DR, Hurley J, Jamieson GG, Kiroff G, Martin CJ, Martin IJ, Nathanson LK, Windsor JA; International Society fir Disease of the Esophagus - Australasian Section.

World J Surg. 2006 Oct;30(10):1856-63.

PMID:
16983477
23.

Surgeon experience and trends in intraoperative complications in laparoscopic cholecystectomy.

Hobbs MS, Mai Q, Knuiman MW, Fletcher DR, Ridout SC.

Br J Surg. 2006 Jul;93(7):844-53.

PMID:
16671070
24.

Multicenter, prospective, double-blind, randomized trial of laparoscopic nissen vs anterior 90 degrees partial fundoplication.

Watson DI, Jamieson GG, Lally C, Archer S, Bessell JR, Booth M, Cade R, Cullingford G, Devitt PG, Fletcher DR, Hurley J, Kiroff G, Martin CJ, Martin IJ, Nathanson LK, Windsor JA; International Society for Diseases of the Esophagus--Australasian Section.

Arch Surg. 2004 Nov;139(11):1160-7.

PMID:
15545560
25.

Impact of laparoscopic cholecystectomy on hospital utilization.

Hobbs MS, Mai Q, Fletcher DR, Ridout SC, Knuiman MW.

ANZ J Surg. 2004 Apr;74(4):222-8.

PMID:
15043732
26.

Preoperative assessment of pancreatic malignancy using endoscopic ultrasound.

Yusoff IF, Mendelson RM, Edmunds SE, Ramsay D, Cullingford GL, Fletcher DR, Zimmerman AM.

Abdom Imaging. 2003 Jul-Aug;28(4):556-62.

PMID:
14580100
27.

Analysis of the Albumin Cobalt Binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction.

Wu AH, Morris DL, Fletcher DR, Apple FS, Christenson RH, Painter PC.

Cardiovasc Toxicol. 2001;1(2):147-51.

PMID:
12213987
28.
29.

Appendicectomy in Western Australia: profile and trends, 1981-1997.

Donnelly NJ, Semmens JB, Fletcher DR, Holman CD.

Med J Aust. 2001 Jul 2;175(1):15-8.

PMID:
11476196
30.

Gallstones. Modern management.

Fletcher DR.

Aust Fam Physician. 2001 May;30(5):441-5. Review.

PMID:
11432016
31.

Finding bile duct injuries using record linkage: a validated study of complications following cholecystectomy.

Valinsky LJ, Hockey RL, Hobbs MS, Fletcher DR, Pikora TJ, Parsons RW, Tan P.

J Clin Epidemiol. 1999 Sep;52(9):893-901.

PMID:
10529030
32.

Complications of cholecystectomy: risks of the laparoscopic approach and protective effects of operative cholangiography: a population-based study.

Fletcher DR, Hobbs MS, Tan P, Valinsky LJ, Hockey RL, Pikora TJ, Knuiman MW, Sheiner HJ, Edis A.

Ann Surg. 1999 Apr;229(4):449-57.

33.

Distal colonic neoplasms predict proximal neoplasia in average-risk, asymptomatic subjects.

Collett JA, Platell C, Fletcher DR, Aquilia S, Olynyk JK.

J Gastroenterol Hepatol. 1999 Jan;14(1):67-71.

PMID:
10029280
34.

Gamma-glutamyl transpeptidase, an ecto-enzyme regulator of intracellular redox potential, is a component of TM4 signal transduction complexes.

Nichols TC, Guthridge JM, Karp DR, Molina H, Fletcher DR, Holers VM.

Eur J Immunol. 1998 Dec;28(12):4123-9.

35.

One hundred liver resections including comparison to non-resected liver-mobilized patients.

Hardy KJ, Fletcher DR, Jones RM.

Aust N Z J Surg. 1998 Oct;68(10):716-21.

PMID:
9768608
36.

The Quality of Surgical Care Project: a model to evaluate surgical outcomes in Western Australia using population-based record linkage.

Semmens JB, Lawrence-Brown MM, Fletcher DR, Rouse IL, Holman CD.

Aust N Z J Surg. 1998 Jun;68(6):397-403.

PMID:
9623457
37.

Colorectal cancer screening by general practitioners: comparison with national guidelines.

Olynyk JK, Aquilia S, Platell CF, Fletcher DR, Henderson S, Dickinson JA.

Med J Aust. 1998 Apr 6;168(7):331-4.

PMID:
9577443
38.

Peptic disease: can we afford current management?

Fletcher DR.

Aust N Z J Surg. 1997 Feb-Mar;67(2-3):75-80. Review.

PMID:
9068546
39.

Flexible sigmoidoscopy screening for colorectal cancer in average-risk subjects: a community-based pilot project.

Olynyk JK, Aquilia S, Fletcher DR, Dickinson JA.

Med J Aust. 1996 Jul 15;165(2):74-6.

PMID:
8692065
40.

Hepatic pathology resulting from mouse hepatitis virus S infection in severe combined immunodeficiency mice.

Huang DS, Emancipator SN, Fletcher DR, Lamm ME, Mazanec MB.

Lab Anim Sci. 1996 Apr;46(2):167-73.

PMID:
8723232
41.
42.

Laparoscopic cholecystectomy in Australia--outcomes and costs.

Fletcher DR.

Surg Endosc. 1995 Nov;9(11):1230-5. No abstract available.

PMID:
8553244
43.

Biliary tract complications of laparoscopic cholecystectomy are detected more frequently with routine intraoperative cholangiography.

Woods MS, Traverso LW, Kozarek RA, Donohue JH, Fletcher DR, Hunter JG, Oddsdottir M, Rossi RL, Tsao J, Windsor J.

Surg Endosc. 1995 Oct;9(10):1076-80.

PMID:
8553206
44.

Abdominal insufflation for laparoscopy: can the risks be reduced?

Fletcher DR.

Aust N Z J Surg. 1995 Jul;65(7):462. No abstract available.

PMID:
7611962
45.

Operative Cholangiogram at Laparoscopic Cholecystectomy.

Fletcher DR.

Semin Laparosc Surg. 1995 Jun;2(2):111-117.

PMID:
10401071
46.

Peptic disease: can we afford current management?

Fletcher DR.

Med J Aust. 1995 May 15;162(10):554-5. No abstract available.

PMID:
7776925
47.
48.

The carcinogenic risks of alcoholic beverages: implications for cancer education.

Burzynski NJ, Yancey JM, Fletcher DR, Flynn MB.

J Cancer Educ. 1995 Spring;10(1):34-6.

PMID:
7772464
49.

Medical Therapy Versus Laparoscopic Surgical Treatment for Ulcer Disease.

Fletcher DR.

Semin Laparosc Surg. 1994 Sep;1(3):144-149.

PMID:
10401050
50.

Laparoscopic adrenalectomy.

Fletcher DR, Beiles CB, Hardy KJ.

Aust N Z J Surg. 1994 Jun;64(6):427-30.

PMID:
8010906

Supplemental Content

Loading ...
Support Center